A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

5.4K views

⸱

DOI:

10.3791/60215

⸱

October 4th, 2019

In This Article

Summary

Described here is a protocol for characterizing modules of biologically synergistic miRNAs and their assembly into short transgenes, which allows simultaneous overexpression for gene therapy applications.

Abstract

The biological relevance of microRNAs (miRNAs) in health and disease significantly relies on specific combinations of many simultaneously deregulated miRNAs rather than the action of a single miRNA. The characterization of these specific miRNAs modules is a fundamental step in maximizing their use in therapy. This is extremely relevant because their combinatorial attributes can be practically exploited. Described here is a method to define a specific miRNA signature relevant to the control of oncogenic chromatin repressors in glioblastoma. The approach first defines a general group of miRNAs that are deregulated in tumors in comparison to normal tissue. The analysis is further refined by differential culture conditions, underscoring a subgroup of miRNAs that are co-expressed simultaneously during specific cellular states. Finally, the miRNAs that satisfy these filters are combined into an artificial polycistronic transgenes, which is based on a scaffold of naturally existing miRNA clusters genes, then used for overexpression of these miRNA modules into receiving cells.

Introduction

miRNAs offer an unmatched opportunity for the development of a broad gene therapy approach to many diseases1,2,3, including cancer4,5. This is based on several unique features of these biological molecules, including their small size6, simple biogenesis7, and natural tendency to function in association8. Many diseases are characterized by specific miRNA expression patterns, which often converge on the regulation of complex biological functions

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Characterization of Functionally Associated miRNAs in Glioblastoma

  1. Analysis of broad differential miRNA expression in glioblastoma vs. brain
    1. First, determine the most significantly deregulated miRNAs in the tumor. This can be achieved using at least three different methods:
      1. Mine the Cancer Genome Atlas, found at https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga, for sequencing data11.
      2. Perform microarray analysis from a fresh operative specimen12.
      3. Use previously published datasets13.<....

Access restricted. Please log in or start a trial to view this content.

Results

This method allowed characterization of a module of three miRNAs that are consistently downregulated in brain tumors, which are co-expressed specifically during neuronal differentiation (Figure 1) and involved in the tumor survival response after therapy (Figure 2). This is accomplished by regulating a complex oncogenic chromatin repressive pathway. This co-expression pattern suggested a strong synergistic activity among these th.......

Access restricted. Please log in or start a trial to view this content.

Discussion

This protocol is based on the notion that rather than functioning in isolation, miRNAs are biologically relevant by working in groups, and these groups are transcriptionally determined by specific cellular contexts26. To justify this approach from a translational perspective, a follow-up protocol that allows recreation of this multi-miRNA pattern in cells/tissues is introduced. This is possible by taking advantage of the relatively simple biogenesis of miRNAs, whereby the recognition of the charac.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors report no conflicts of interest.

Acknowledgements

The authors wish to thank the members of the Harvey Cushing Neuro Oncology Laboratory for support and constructive criticism. This work was supported by NINDS grants K12NS80223 and K08NS101091 to P. P.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
0.4% low melting temperature agarose IBI ScientificIB70058
0.45 µM sterile filter unitMerck MilliporeSLH033RS
1.5 mL Microcentrifuge tubeEppendorf22431081
6-Well plates Greiner Bio-One657160
Athymic mice (FoxN1 nu/nu)Envigo069(nu)/070(nu/+)
B-27 Supplement Thermo Fisher Scientific12587010
Cell culture flaskGreiner Bio-One660175
Cell Scraper, 16cmSarstedt83.1832
Cesium 137 irradiator JL Sheperd and AssociatesCore Facility (Harvard Medical School)
ChloroformSigma-Aldrich439142-4L
DMEM, high glucose, pyruvate Thermo Fisher Scientific11995040
Dulbecco’s phosphate-buffered saline Gibco14190144
Eosin Y solution Sigma-AldrichE4009
Fetal Bovine Serum Sigma-AldrichF9665
Formalin solutionSigma-AldrichHT501128
GlutaMAX Supplement Thermo Fisher Scientific35050061
HEK-293American Type Culture CollectiATCC CRL-1573
Hematoxylin solutionSigma-Aldrich1051750500
Human primary glioma stem-like cells (GBM62)Provided by Dr. E. A. Chiocca (Brigham and Women’s Hospital, Boston, MA)
Human primary glioma stem-like cells (MGG4)Provided by Dr. Hiroaki Wakimoto (Massachusetts General Hospital, Boston, MA)
Lentiviral vector pCDH-CMV-MCS-EF1-copGFPSystem BiosciencesCD511B-1
Lipofectamine 2000 Thermo Fisher Scientific11668019
Microcentrifuge refrigeratedEppendorfmodel no. 5424 R, cat. no.5404000138
Mounting medium Thermo Fisher Scientific4112APG
Nalgene High-Speed Polycarbonate Round Bottom Centrifuge Tubes Thermo Fisher Scientific 3117-0380PK
NanoDropThermo Fisher Scientific2000c
Neural Progenitor cells (NPC)Provided by Dr. Jakub Godlewski (Brigham and Women’s Hospital, Boston, MA)
Neurobasal Medium Thermo Fisher Scientific21103049
Nikon eclipse Ti motorized fluorescent microscope systemNikon, Japan14314
Opti-MEMThermo Fisher Scientific31985088
PCR tubes Sigma-AldrichCLS6571-960EA
Penicillin-Streptomycin Thermo Fisher Scientific15140122
Petri-Dishes 94/16 Greiner Bio-One632180
Poly-D-Lysine Sigma- AldrichP4707
Recombinant Human EGF PeproTech AF-100-15
Recombinant Human FGF-basic PeproTech AF-100-18B
Retinoic acidGibco12587-010 
RNA Miniprep KitDirect-zolR2050
S1000 Thermal Cycler Bio-Rad1852196
Small Animal Image-Guided Micro Irradiator Xstrahal Life Sciences, UKCore facility (Dana-Farber Cancer Institute, Boston, MA)
Sorvall WX+ Ultracentrifuge Thermo Fisher Scientific 75000100
StemPro Accutase Thermo Fisher ScientificA1110501
StepOne Real-Time PCR SystemApplied Biosystems 4376357
SterilGARD biosafety cabinet The Baker CompanySG403A-HE
SucroseSigma-AldrichS9378
T98-GAmerican Type Culture CollectiATCC CRL-1690
TaqMan MicroRNA Reverse Transcription Kit Thermo Fisher Scientific4366596
TaqMan Universal PCR Master MixThermo Fisher Scientific4324018
TemozolomideTocris Bioscience2706
Tissue-Tek optimum cutting temperature Fisher ScientificNC9636948
TRIzol Reagent Thermo Fisher Scientific15596026Lysis reagent
U251-MGAmerican Type Culture CollectiATCC HTB-17
U87-MG American Type Culture CollectiATCC HTB-14
ViraPower Lentivector Expression system Thermo Fisher ScientificK4970-00
Water, HPLC gradeFisherW54
Xylene Sigma-Aldrich534056

References

  1. Wu, Y. E., Parikshak, N. N., Belgard, T. G., Geschwind, D. H. Genome-wide, integrative analysis implicates miRNA dysregulation in autism spectrum disorder. Nature Neuroscience. 19, 1463-1476 (2016).
  2. Esteller, M. Non-coding RNAs in human disease. Nature Reviews Gene....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

MicroRNA ModulesGlioblastoma TherapyArtificial Polycistronic TransgenesmiR-17-92 ScaffoldTargetScan AnalysisToppGene SuiteVenn Diagram FunctionRNA Structure PredictionTemozolomide ResistanceNeural Stem Cells